Pharmaceutical

Brenda Dooley, Managing Director, Axis Healthcare Consulting

From this video you will learn more about:

NCPE requirements & challenges with sourcing local Irish data for HTA submissions
3 key questions to ask (i) What data do I need (ii) Where to source it (iii) What if there is no data.
Importance of a systematic approach- data collection files on (i) demographics-CSO (ii) disease specific data – patient registries/expert opinion via market research with clinical specialist (iii) Irish costs- HSE case mix data published in “ready reckoner 2013”, Hospital data, HSE PCRS data (iv) Outcomee data & HRQOL data
Document approach taken for NCPE & efforts considered.

[su_button url=”https://www.thepmi.com/pmi-player/pharmaceutical/market-access-data-collection-methods/” style=”flat” background=”#8d44ad” size=”5″]View Video[/su_button]

Brenda Dooley, Managing Director, Axis Healthcare Consulting

From this video you will learn more about:

The importance of putting a strategic market access plan in place
Challenges in securing market access for products in Ireland & how to respond to these challenges
The need to have an outward perspective and the change in mindset this often necessitates for companies

[su_button url=”https://www.thepmi.com/pmi-player/pharmaceutical/market-access-for-pharma/” style=”flat” background=”#8d44ad” size=”5″]View Video[/su_button]

Dr Máirín Ryan, Director of Health Technology Assessment at the Health Information and Quality Authority Ireland (HIQA)

From this video you will learn more about:

The scope of the role of HIQA in relation to HTA’s- broadly the generation of independent advice that informs investment or disinvestment decisions- does it work, who will benefit, cost, value for money, recommendations on the reorganisation of healthcare delivery
HTA’s cover drugs, diagnostics, surgical procedures, public health interventions
Guidelines from HIQA for HTA’s
Clinical Guidelines in particular National Clinical Guidelines Programs are given advice by HTA
New focus on (i) European network of HTA agencies to harmonise methodologies & leverage work done in other markets (ii) collaborative work with licencing authorities ie EMEA- early advise on clinical trials prog needed to achieve licensing & reimbursement

[su_button url=”https://www.thepmi.com/pmi-player/pharmaceutical/the-role-of-hiqa/” style=”flat” background=”#8d44ad” size=”5″]View Video[/su_button]

Alan Downey, Nestle Nutrition

This video will give you a better understanding of:

Assessing financial performance- profit & loss accounts- success of business relative to plan
Identifying reasons for under/over achievement of budget
Determining key KPI’s for the business
The importance of forecasting accuracy
Business performance and the need to consider the macroenvironment—competitors & levels of activity & investment in the therapy area.

[su_button url=”https://www.thepmi.com/pmi-player/pharmaceutical/financial-planning-for-pharma/” style=”flat” background=”#8d44ad” size=”5″]View Video[/su_button]

Orlaith Brennan

Orlaith Brennan

Simon Nugent

Simon Nugent Synopis

Voxpops – Preview

Voxpops

PMI Business Day

Martin Fitzgerald

President's Vision

Data collection methods

Market Access for Pharma

What is HIQA?

Financial Planning for Pharma